CD4 and non-small cell lung carcinoma: Given our initial data that Meflin expression in CAFs correlated with the favorable outcomes of NSCLC patients treated with ICB, it was an unexpected finding that the repertoire of TILs was almost comparable between Meflin-high and Meflin-low groups, except for CD4+ T cells.